"Procarbazine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
| Descriptor ID |
D011344
|
| MeSH Number(s) |
D02.065.277.727 D02.241.223.100.100.655 D02.455.426.559.389.127.085.655
|
| Concept/Terms |
Procarbazine Hydrochloride- Procarbazine Hydrochloride
- Hydrochloride, Procarbazine
- Procarbazine Monohydrochloride
- Monohydrochloride, Procarbazine
|
Below are MeSH descriptors whose meaning is more general than "Procarbazine".
Below are MeSH descriptors whose meaning is more specific than "Procarbazine".
This graph shows the total number of publications written about "Procarbazine" by people in this website by year, and whether "Procarbazine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Procarbazine" by people in Profiles.
-
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. J Clin Oncol. 2022 08 10; 40(23):2539-2545.
-
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012 Jun 05; 156(11):757-66, W-260.
-
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. Ann Intern Med. 2012 Jun 05; 156(11):I-36.
-
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol. 2011 Jun; 13(6):649-59.
-
A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis. J Neurooncol. 2008 Sep; 89(2):187-93.
-
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms. Br J Cancer. 2006 Nov 20; 95(10):1424-31.
-
Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors. Neurology. 2006 Jun 13; 66(11):1661-7.
-
Something old, something new.... Leuk Lymphoma. 2006 Apr; 47(4):576-7.
-
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol. 2006 Apr; 8(2):183-8.
-
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J Neurooncol. 2003 Nov; 65(2):127-34.